|
|
Honglin Wang, Thorsten Peters, Anca Sindrilaru, Daniel Kess, Tsvetelina Oreshkova, Xue-Zhong Yu, Anne Maria Seier, Heike Schreiber, Meinhard Wlaschek, Robert Blakytny, Jan Röhrbein, Guido Schulz, Johannes M. Weiss, Karin Scharffetter-Kochanek
J Clin Invest. 2008;
118(7):2629
doi:10.1172/JCI34916
Abstract |
Full text
| PDF
| Supplemental material

D
ysfunctional Tregs have been identified in individuals with psoriasis. However, their role in the pathogenesis of the disease remains unclear. Here we explored the effect of diminished CD18 (β2 integrin) expression on the function of CD4+CD25+CD127– Tregs using the Cd18 hypomorphic (Cd18hypo) PL/J mouse model of psoriasis that closely resembles the human disease. We found that reduced CD18 expression impaired cell-cell contact between Tregs and DCs. This led to dysfunctional Tregs, which both failed to suppress the pathogenic T cells and promoted the onset and severity of the disease. This failure was TGF-β–dependent, as Tregs derived from Cd18hypo PL/J mice had diminished TGF-β1 expression. Adoptive transfer of Tregs expressing wild-type levels of CD18 into affected Cd18hypo PL/J mice resulted in a substantial improvement of the psoriasiform skin disease, which did not occur upon coinjection of the cells with TGF-β–specific neutralizing antibody. Our data indicate a primary dysfunction of Cd18hypo Tregs, allowing subsequent hyperproliferation of pathogenic T cells in the Cd18hypo PL/J mouse model of psoriasis. This study may provide a step forward in our understanding of the unique role of CD18 expression levels in avoiding autoimmunity.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(10)
| Title and authors |
Publication |
Year |
Controlled Release Formulations of IL-2, TGF-β1 and Rapamycin for the Induction of Regulatory T Cells
Siddharth Jhunjhunwala, Stephen C. Balmert, Giorgio Raimondi, Eefje Dons, Erin E. Nichols, Angus W. Thomson, Steven R. Little
|
Journal of Controlled Release
|
2012 |
All creatures great and small: regulatory T cells in mice, humans, dogs and other domestic animal species
O.A. Garden, D. Pinheiro, F. Cunningham
|
International Immunopharmacology
|
2011 |
Preferential Replication of Vaccinia Virus in the Ovaries is Independent of Immune Regulation Through IL-10 and TGF-β
Yuan Zhao, Yan Fei Adams, Michael Croft
|
Viral Immunology
|
2011 |
TGF- : the sword, the wane, and the shield of FOXP3+ regulatory T cells
D. Q. Tran
|
Journal of Molecular Cell Biology
|
2011 |
Adenosine deaminase activity, trypsin inhibitory capacity and total antioxidant capacity in psoriasis
M Hashemi, H Mehrabifar, M Daliri, S Ghavami
|
Journal of the European Academy of Dermatology and Venereology
|
2010 |
Extracellular Adherence Protein of Staphylococcus aureus Suppresses Disease by Inhibiting T-Cell Recruitment in a Mouse Model of Psoriasis
Honglin Wang, Julia von Rohrscheidt, Jan Roehrbein, Thorsten Peters, Anca Sindrilaru, Daniel Kess, Klaus T Preissner, Karin Scharffetter-Kochanek
|
J Investig Dermatol
|
2009 |
Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis
C. Maenhaut, J.E. Dumont, P.P. Roger, W.C.G. van Staveren
|
Carcinogenesis
|
2009 |
Psoriasis
Frank O. Nestle, Daniel H. Kaplan, Jonathan Barker
|
N Engl J Med
|
2009 |
Could the lower frequency of CD8+CD18+CD45RO+ lymphocytes be biomarkers of human VL?
J. Clarencio, C. I. de Oliveira, C. Favali, O. Medina, A. Caldas, C. H. Costa, D. L. Costa, C. Brodskyn, A. Barral, M. Barral-Netto
|
International Immunology
|
2008 |
Regulatory T Cells Control VEGF-Dependent Skin Inflammation
Ingrid Teige, Henning Hvid, Lars Svensson, Peter Helding Kvist, Kåre Kemp
|
J Investig Dermatol
|
2008 |
|